Sign up
Quantellect · Congress · Trade Detail
NYSE: RDYDr. Reddy’s Laboratories Ltd ADR
RepublicanHouse

Michael T. McCaul bought Dr. Reddy’s Laboratories Ltd ADR (NYSE: RDY)

Michael T. McCaul (R-TX), a U.S. Representative, has disclosed 8 trades in Dr. Reddy’s Laboratories Ltd ADR (RDY) since 2014, 4 purchases and 4 sales, worth an estimated $663K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).

The trade highlighted here is a purchase: Michael T. McCaul bought $100,001 - $250,000 of Dr. Reddy’s Laboratories Ltd ADR (NYSE: RDY) on March 21, 2014. Since that trade, RDY is up +63.09% against the S&P 500 up +380.20%, an outperformance of -317.11%.

Across these filings, Michael T. McCaul has been a balanced trader of RDY (a buy-to-sell ratio of 1.00). The most recent disclosed RDY transaction shown was dated October 12, 2015. Each row in the table below links to that trade and its post-trade performance versus the market.

Data updated

RDY trades
8
Disclosed Vol
$663K
Buys
4
50%
Sells
4
50%
Buy / Sell
1.00
ratio
First → Last
2014–2015

Michael T. McCaul's RDY trades vs the price

RDY is up +63.09% since Michael T. McCaul bought on March 21, 2014, versus +380.20% for the S&P 500.

Performance since this trade

Price change since trade
+63.09%
S&P 500 change since trade
+380.20%
Outperformance vs S&P 500
-317.11%

All Michael T. McCaul RDY trades

TradedTypeSizeReturnEst. profit
October 12, 2015SELL$10.59+11.01%
October 28, 2014SELL$8.20+43.50%
October 28, 2014SELL$8.20+43.50%
March 21, 2014BUY$7.21+63.09%-$129K
March 21, 2014BUY$7.21+63.09%-$129K
March 21, 2014SELL$7.21+63.09%
January 3, 2014BUY$6.43+82.88%-$23K
January 3, 2014BUY$6.43+82.88%-$23K

Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.

Michael T. McCaul & RDY trading FAQ

Is it legal for Michael T. McCaul to trade Dr. Reddy’s Laboratories Ltd ADR (RDY) stock?

Yes. Members of Congress are allowed to trade individual stocks, including Dr. Reddy’s Laboratories Ltd ADR (RDY), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.

When did Michael T. McCaul buy RDY?

Michael T. McCaul disclosed a purchase of $100,001 - $250,000 of Dr. Reddy’s Laboratories Ltd ADR (RDY) on March 21, 2014, according to public STOCK Act filings.

How has RDY performed since Michael T. McCaul's trade?

Since Michael T. McCaul bought RDY on March 21, 2014, the stock is up +63.09%, versus +380.20% for the S&P 500 over the same period, an outperformance of -317.11%.

How many times has Michael T. McCaul traded RDY?

Michael T. McCaul has disclosed 8 RDY trades since 2014 (4 purchases and 4 sales). Every disclosed trade is listed on this page.

How soon must members of Congress disclose a trade?

Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.

Where can I see all congressional RDY trades?

Quantellect tracks every disclosed congressional trade in Dr. Reddy’s Laboratories Ltd ADR (RDY) on the Dr. Reddy’s Laboratories Ltd ADR congressional trading page, which aggregates filings across all members of Congress.

Michael T. McCaul's RDY tradesAll congressional filings for Dr. Reddy’s Laboratories Ltd ADRMichael T. McCaul's full profile

Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.